Form 483

UCLA Health, UCLA Blood & Platelet Center Form 483, 2012-03-20

FDA issued a Form 483 to UCLA Health, UCLA Blood & Platelet Center on 2012-03-20 with 1 public-safe observation.

483· Form 483 issued1 observation

UCLA Health, UCLA Blood & Platelet Center · Los Angeles, United States · Issued March 20, 2012

Overview

  • 1 public-safe observation is available for this inspection.
  • 1 structured CFR citation is represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

20 Mar 2012
21 CFR 640.3(a)(1)

Donor suitability procedures not followed

Cited by Yvonne C Wilkes

Inspected site

UHUCLA Health, UCLA Blood & Platelet CenterLos Angeles, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 640.3(a)(1)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 1 observation

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere